[Rapport de recherche] Le marché des dispositifs d'assistance ventriculaire gauche devait atteindre 1 272,08 USD millions en 2021 & il devrait croître à un TCAC de 5,1 % de 2022 à 2028.
Le dispositif d'assistance ventriculaire gauche aide le ventricule gauche du cur à pomper le sang vers le reste du corps. Il est également connu comme un dispositif d'assistance circulatoire mécanique qui aide à maintenir une bonne circulation sanguine dans le corps. L'augmentation de la prévalence des troubles cardiovasculaires et de l'insuffisance cardiaque ainsi qu'une augmentation significative de la population gériatrique et obèse entraînent la croissance du marché des dispositifs d'assistance ventriculaire gauche. Cependant, les rappels de produits croissants et les complications associées aux dispositifs d'assistance ventriculaire gauche entravent la croissance du marché.
Le rapport offre des informations et une analyse approfondie du marché des dispositifs d'assistance ventriculaire gauche, en mettant l'accent sur divers paramètres tels que les tendances du marché, les avancées technologiques, la dynamique du marché et l'analyse du paysage concurrentiel des principaux acteurs du marché mondial. Il inclut également l'impact de la pandémie de COVID-19 sur le marché dans toutes les régions. En raison de la pandémie de COVID-19, de nombreuses autorités sanitaires se sont concentrées sur les soins liés à la pandémie. Ils ont évité le contact humain en raison de la transmission croissante et de la pression sur les ressources de santé en reportant les chirurgies électives, en suspendant les cliniques externes et en triant les employés impliqués dans les soins d'urgence. En outre, de nombreux pays ont imposé des restrictions à l'accès du personnel non clinique à l'établissement et aux invités. De plus, il y a eu une augmentation de la prévalence des maladies cardiovasculaires chez les patients atteints de COVID-19, ce qui a encore créé la demande de dispositifs d'assistance ventriculaire gauche, ce qui a entraîné une croissance du marché. Les récentes directives COVID-19 pour les professionnels de la santé ont suggéré de se concentrer sur les soins urgents et le triage des cas pour reporter les chirurgies électives et les rendez-vous à la clinique, avec une transition vers des soins virtuels le cas échéant.
Insights stratégiques
De plus, les fabricants de nombreux dispositifs d'assistance ventriculaire gauche répondent aux urgences par le biais de diverses stratégies telles que la fabrication d'EPI pour les travailleurs de la santé, la distribution de médicaments pharmaceutiques et d'autres activités. De plus, en novembre 2020, Medtronic et la fondation Medtronic ont engagé un soutien financier de 3,8 millions de dollars américains au niveau mondial pour fournir un soutien aux travailleurs de la santé en termes de nourriture, de soutien opérationnel, de soutien en santé mentale, de kits d'EPI et autres. Ainsi, la pandémie a eu un impact négatif à court terme sur le marché des dispositifs d'assistance ventriculaire gauche.
Le marché des dispositifs d'assistance ventriculaire gauche est segmenté en fonction du type de flux, de la conception, de l'application et de la géographie. Par région, le marché est segmenté en Amérique du Nord, Europe, Asie-Pacifique, Moyen-Orient & Afrique et Sud & Amérique centrale.
< strong>Régions lucratives pour le marché des dispositifs d'assistance ventriculaire gauche
Informations sur le marché
Augmentation de l'incidence des maladies et procédures cibles
Selon l'Organisation mondiale de la santé (OMS), les maladies cardiovasculaires (MCV) sont l'une des principales causes de décès dans le monde. monde. Les antécédents familiaux, l'origine ethnique et l'âge sont quelques-uns des principaux facteurs qui augmentent la prévalence des maladies cardiovasculaires et des accidents vasculaires cérébraux. La prévalence des maladies cardiovasculaires augmente également en raison de l'usage du tabac ; hypertension artérielle (hypertension); taux de cholestérol élevé; manque d'exercice; mauvaise habitudes alimentaires; consommation excessive d'alcool; et des maladies telles que la dyslipidémie, l'obésité et le diabète. Selon l'American Heart Association, environ 41,4 % des adultes aux États-Unis souffriront d'hypertension d'ici 2030 (une augmentation de 8,4 % par rapport à 2012). L'organisation estime également que le coût mondial des maladies cardiovasculaires atteindra 1 044 milliards de dollars américains d'ici 2030, contre 863 milliards de dollars américains en 2010. De plus, selon les estimations de l'OMS, les décès dus aux maladies cardiovasculaires dans le monde passeront d'environ 17,9 millions en 2016 à 23,6 millions d'ici 2030. Le rapport d'Emory Healthcare indique que les États-Unis ont enregistré environ 5 millions de cas d'insuffisance congestive en 2022 et qu'environ 550 000 nouveaux cas ont été diagnostiqués chaque année dans le pays. En outre, le pays signale environ 287 000 décès dus à une insuffisance cardiaque chaque année.
Selon Temple Health, 70,9 % des patients ont reçu des greffes cardiaques en un an, et la moyenne de la liste d'attente la plus courte était de 55,2 % aux États-Unis en 2021. L'augmentation de la liste d'attente de transplantation cardiaque dans le monde a propulsé l'utilisation de dispositifs d'assistance ventriculaire gauche (LVAD) pour les patients atteints d'insuffisance cardiaque en phase terminale afin d'augmenter la fraction d'éjection et prévenir les défaillances d'organes. Par conséquent, la prévalence croissante des maladies cardiovasculaires et de l'insuffisance cardiaque et la longue liste d'attente pour une transplantation cardiaque propulsent l'adoption des LVAD, qui stimulent la croissance du marché des dispositifs d'assistance ventriculaire gauche.
Type d'informations basées sur les flux
En fonction du type de flux, le marché mondial des dispositifs d'assistance ventriculaire gauche est segmenté en pulsatile et non pulsatile. En 2021, le segment non pulsatile représentait une part de marché plus importante, et il devrait en outre enregistrer un TCAC plus élevé sur le marché au cours de la période 2022-2028.
Marché des dispositifs d'assistance ventriculaire gauche, par produit 2021 et 2028
Insights basés sur la conception< /p>
Sur la base de la conception, le marché des dispositifs d'assistance ventriculaire gauche est divisé en implantable dispositifs d'assistance ventriculaire et dispositifs d'assistance ventriculaire transcutanée. Le segment des dispositifs d'assistance ventriculaire implantables détenait une plus grande part de marché en 2021 et devrait enregistrer un TCAC plus élevé au cours de la période de prévision.
Insights basés sur les applications
En fonction de l'application, le marché des dispositifs d'assistance ventriculaire gauche est segmenté en thérapie de destination, transition vers la transplantation, transition vers la candidature et transition vers la récupération. Le segment de la thérapie de destination détenait la plus grande part de marché en 2021 et devrait enregistrer le TCAC le plus élevé au cours de la période de prévision.
Les acteurs du marché des dispositifs d'assistance ventriculaire gauche adoptent des stratégies organiques telles que les lancements de produits, les approbations de produits et l'expansion pour étendre leur empreinte et leur portefeuille de produits dans le monde entier et répondre à la demande croissante. En juin 2020, Abiomed a annoncé l'approbation de la Food and Drug Administration (FDA) des États-Unis pour sa demande d'exemption de dispositif expérimental pour le démarrage d'une étude de faisabilité précoce avec un premier essai sur l'homme pour la pompe cardiaque Impella ECP.< /p>
Insights basés sur la géographie
Par géographie, le marché des dispositifs d'assistance ventriculaire gauche est segmenté en Amérique du Nord (États-Unis, Canada et Mexique ), Europe (France, Allemagne, Royaume-Uni, Espagne, Italie et reste de l'Europe), Asie-Pacifique (Chine, Inde, Japon, Australie, Corée du Sud et reste de l'APAC), Moyen-Orient & Afrique (Arabie Saoudite, Émirats Arabes Unis, Afrique du Sud et Reste de la MEA), et Sud & Amérique centrale (Brésil, Argentine et reste de l'Amérique du Sud et centrale).
Informations sur l'entreprise
ABIOMED Inc, Abbott Laboratories, Medtronic Plc, LivaNova Plc, Jarvik Heart Inc, Terumo Corp, Berlin Heart GmbH, BiVACOR Inc, Evaheart Inc et BioVentrix Inc. sont parmi les principales sociétés opérant sur le marché des dispositifs d'assistance ventriculaire gauche.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Global left ventricular assist device market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for left ventricular assist device market. According to the Centers for Disease Control and Prevention (CDC), ~6.2 million adults in the US suffer from heart failure, and it was the cause of death of ~697,000 people in 2018. According to the data provided by the American Heart Association Inc., ~1 million new heart failure cases are registered annually in the US, and more than 8 million people are estimated to suffer from heart failure by 2030. According to the Health Research Funding Organization, ~555,000 people were diagnosed with the beginning stages of heart failure in the US in 2021, and ~300,000 patients in the US qualify for a left ventricular assist device (LVAD) because of their terminal heart conditions. Cardiovascular diseases (CVDs) generally lead to heart failure or terminal heart disease, which bolsters the demand for LVADs that ensure proper heart functioning. Such aforementioned facto acts as a standalone factor responsible for the overall market growth of left ventricular assist device in the US during the forecast period of 2022-2028.
ABIOMED Inc, Abbott Laboratories, Medtronic Plc, LivaNova Plc, Jarvik Heart Inc, Terumo Corp, Berlin Heart GmbH, BiVACOR Inc, Evaheart Inc, and BioVentrix Inc, and among others are among the leading companies operating in the left ventricular assist device market.
Left ventricular assist device is a mechanical pump implanted in heart failure. This device helps the left ventricle of the heart in pumping blood to the rest of the body. It is also known as a mechanical circulatory support device that helps in maintaining proper blood circulation within the body.
Increasing incidence of target diseases and procedures and growing geriatric population are the most significant factors responsible for the overall market growth.
Based on type of flow segment, the non-pulsatile segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.
Based on the application, destination therapy segment took the forefront leaders in the worldwide market by accounting largest share in 2021.
Implantable ventricular assist device segment dominated the global left ventricular assist device market and accounted for the largest market share during the forecast period of 2022-2028.
The List of Companies - Left Ventricular Assist Device Market
- ABIOMED Inc
- Abbott Laboratories
- Medtronic Plc
- LivaNova Plc
- Jarvik Heart Inc
- Terumo Corp
- Berlin Heart GmbH
- BiVACOR Inc
- Evaheart Inc
- BioVentrix Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Oct 2022
Digital PCR (dPCR) Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology [Droplet Digital PCR (ddPCR) and BEAMing Digital PCR], Component (Instruments, Reagents and Consumables, and Software and Services), Application (Clinical, Research, and Forensic), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organization), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Oct 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography